CCO Treatment Updates
Beyond Chemotherapy: Current and Future Molecular-Targeted Therapy in Ovarian Cancer
CCO Slidesets
The Need for Molecular-Targeted Therapy
 |
|
Michael V. Seiden, MD, PhD, reviews the role of molecular-targeted therapy in ovarian cancer.
Format: Microsoft PowerPoint (.ppt) |
File size: 4.08 MB
| Date posted: 2/11/2009
|
VEGF Targeted Therapy in Ovarian Cancer: Basis & Directions
 |
|
Robert A. Burger, MD, discusses the rationale for using VEGF inhibitors in ovarian cancer and reviews current phase II and III trials evaluating these agents in the frontline and recurrent setting.
Format: Microsoft PowerPoint (.ppt) |
File size: 2.96 MB
| Date posted: 2/11/2009
|
Targeting EGF and Other Signal Transduction Pathway
 |
|
Thomas J. Herzog, MD, discusses targeting EGF and other approaches such as Src inhibition, c-Met inhibition, PARP inhibition, and mTOR inhibition as therapy for ovarian cancer.
Format: Microsoft PowerPoint (.ppt) |
File size: 1.52 MB
| Date posted: 2/12/2009
|
Immunologic-Targeted Therapy in Ovarian Cancer
 |
|
George Coukos, MD, PhD, discusses immunologic-targeted therapy as a therapeutic strategy for ovarian cancer.
Format: Microsoft PowerPoint (.ppt) |
File size: 2.92 MB
| Date posted: 2/13/2009
|
Disclaimer:
The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.
|
Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.
Contact Info
Educational grant provided by:
Educational grants support only the CME-certified components of this program.
|
|